Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.Frank Kroschinsky, Gerhard Ehninger, Kristina Hölig et al.|PubMed|2005Cited by 61
CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionDuohui Jing, Martin Bornhäuser, Rainer Ordemann et al.|Bone Marrow Transplantation|2010Cited by 56
Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Marc Schmitz, Christian Thiede et al.|Blood|2011Cited by 50
Efficacy of single‐dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myelomaFrank Kroschinsky, Gerhard Ehninger, Kristina Hölig et al.|Transfusion|2006Cited by 33
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Johannes Schetelig, Helmuth Schmidt et al.|Bone Marrow Transplantation|2020Cited by 23